在尼日利亚拉各斯的宫癌患者中,基于并发症状态的死亡风险分层
Idris O Ola1, Adeyemi A Okunowo2,3, Muhammad Y Habeebu4,5,6
1Department of Clinical and Community Service, Blue-Pink Center for Women's Health, Lagos 100361, Nigeria.
International health
|February 8, 2025
概括
伴随性疾病显著增加了尼日利亚的宫癌死亡风险. 较高的并发性得分,特别是在晚期,与更糟糕的结果有关,突显了综合护理的需要.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 伴随性疾病显著放大了癌症死亡风险.
- 在尼日利亚,大约26%的宫癌患者患有并发症.
- 伴随性疾病对尼日利亚子宫癌结局的影响仍未得到充分研究.
研究的目的:
- 调查尼日利亚宫癌患者的并发症和死亡风险之间的关联.
- 用高血压增强的查尔森并发症指数 (hCCI) 来量化并发症对子宫癌结局的影响.
主要方法:
- 来自拉各斯大学教学医院和NSIA-LUTH癌症中心的数据分析 (2015年1月 - 2021年12月).
- 使用高血压增强的查尔森并发症指数 (hCCI) 进行并发症评估.
- 采用Cox比例危险模型来估计宫癌死亡率的危险比率 (HRs).
主要成果:
- 观察到宫癌死亡率为每100名女性年 30.1.
- 与hCCI为0.0的女性相比,hCCI得分为2-6的女性的死亡风险显著增加 (HR1.68),而hCCI为0.
- 随着hCCI的增加,死亡风险升级,特别是在晚期转移性宫癌中 (为hCCI 2-6调整HR 4.15).
结论:
- 宫癌死亡风险与伴随性疾病得分的增加直接相关.
- 在临床评估中建议对宫癌患者进行常规的并发症评分.
- 多学科的癌症护理团队可以加强宫癌患者的临床和心理社会管理.
相关概念视频
01:21Cancer Survival Analysis
321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321
01:20Comparing the Survival Analysis of Two or More Groups
127
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
127
01:20Actuarial Approach
54
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
54
01:24Kaplan-Meier Approach
80
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
80
01:25Statistical Methods for Analyzing Epidemiological Data
291
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
291